Author:
Santonja Camille,Gougis Paul,Dumas Elise,Rolland Debord Camille,Merle Patrick,Belliere Aurelie,Campedel Luca,Abbar Baptiste
Reference45 articles.
1. Lung cancer trends and tumor characteristic changes over 20 years (2000-2020): Results of three French consecutive nationwide prospective cohorts' studies;D Debieuvre;Lancet Reg Health Eur,2022
2. Clinical Pharmacology and Interplay of Immune Checkpoint Agents: A Yin-Yang Balance;A Geraud;Annu Rev Pharmacol Toxicol,2021
3. Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study;D R Gandara;J Thorac Oncol,2018
4. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer;J Brahmer;N Engl J Med,2015